BioMedPartners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
7
- Investments
-
108
- Portfolio
-
17
- Exits
-
52
BioMedPartners General Information
Company Description
Founded in 2003, BioMedPartners is a venture capital firm based in Basel, Switzerland. The firm prefers to invest in the life science, biotech, med tech, and diagnostic, sectors across Central Europe.
Business Details
Website
www.biomedvc.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Elisabethenanalge 11
- 4051 Basel
- Switzerland
BioMedPartners Investments (108)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ImmunOs Therapeutics | 05-Aug-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Tubulis | 14-Mar-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Mediphage Bioceuticals | 08-Feb-2024 | Biotechnology | Pre-Clinical Trials | |||
| TOLREMO therapeutics | 20-Sep-2023 | Biotechnology | Clinical Trials - Phase 1 | |||
| Vaximm | 03-Nov-2022 | Drug Discovery | Generating Revenue | |||
| TRiCares | 15-Sep-2022 | Surgical Devices | Generating Revenue | |||
| ImmunOs Therapeutics | 05-Jun-2022 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Tubulis | 03-May-2022 | Drug Discovery | Pre-Clinical Trials | |||
| Precirix | 16-Mar-2022 | Later Stage VC | Biotechnology | Clinical Trials - Phase 2 | ||
| Scenic Biotech | 10-Mar-2022 | Later Stage VC | Drug Discovery | Pre-Clinical Trials |
BioMedPartners Exits (52)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Genebio | 14-Nov-2024 | Out of Business | |
| Cardior | 25-Mar-2024 | ||
| BC Platforms | 01-Mar-2024 | ||
| Humedics | 08-Dec-2022 | ||
| Imetric 4D | 01-Dec-2022 | ||
| Ayoxxa Biosystems | 11-Nov-2022 | ||
| EyeSense | 01-Nov-2022 | ||
| Anergis | 01-Aug-2021 | ||
| Sonetik | 01-Jun-2021 | Secondary Transaction - Private | |
| Ventaleon | 01-Jan-2020 | Out of Business |
BioMedPartners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
BioMedPartners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
BioMedPartners Co-Investors (56)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Gimv | 3 |
|
|
||
| High-Tech Gründerfonds |
|
|
|||
| Inkef |
|
|
|||
| Schroders Capital |
|
|
|||
| Forbion |
|
|
BioMedPartners FAQs
-
What is BioMedPartners?
Founded in 2003, BioMedPartners is a venture capital firm based in Basel, Switzerland.
-
When was BioMedPartners founded?
BioMedPartners was founded in 2003.
-
Where is BioMedPartners headquartered?
BioMedPartners is headquartered in Basel, Switzerland.
-
What is BioMedPartners's total asset value?
BioMedPartners has around in total assets under management.
-
How many investments has BioMedPartners made?
BioMedPartners has made 108 investments.
-
What has BioMedPartners invested in?
BioMedPartners has made numerous investments in companies like ImmunOs Therapeutics, Tubulis, and Mediphage Bioceuticals within the Drug Discovery and Biotechnology industries.
-
What has BioMedPartners invested in recently?
BioMedPartners's latest investment was on 05-Aug-2024 in ImmunOs Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
